About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
Novocure image

Novocure

Rank#5110
Market Cap1.84B
CountryJersey
Summary
History
Mission
Vision
References
Summaryarrow
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Historyarrow

Novocure was founded on a big idea from Dr. Yoram Palti – professor of electrical engineering and a cancer survivor – to fight cancer with an innovative therapy called Tumor Treating Fields therapy. Novocure is dedicated to unlocking the potential of Tumor Treating Fields and improving the lives of cancer patients.

Missionarrow
Our mission is to extend lives by developing, manufacturing and commercializing innovative cancer treatments that empower patients, their families and their physicians.
Visionarrow
Our vision is to make Tumor Treating Fields therapy the standard of care for all solid tumor types.
Referencesarrow

https://in.investing.com/equities/novocure-ltd

https://finance.yahoo.com/quote/NVCR/profile?p=NVCR

https://www.crunchbase.com/organization/novocure

https://sec.report/CIK/0001645113

https://companiesmarketcap.com/

https://www.novocure.com

Share

Leadership team
M
Mr. William F. Doyle (Exec. Chairman)
M
Mr. Asaf Danziger (Pres, CEO & Director)
M
Ms. Ashley Cordova (Chief Financial Officer)
Products / Services
Health Care, Medical Device
Number of Employees
1,000 - 20,000
Address
Jersey, Arkansas, United States
Established
2000-01-01
Company Registration
SEC CIK number: 0001645113
Revenue
500M - 1B
Traded as
NVCR
Website
https://www.novocure.com
Social Media
linkedinfacebookx
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo